Corvus Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$11.91

-0.09 (-0.75%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +281.2% upside

Low Target $29.32

Average Target $45.40

High Target $54.46

Current Price $11.91

Current
$11.91

Target
$45.40

$29.32 $45.40 avg $54.46

Scenario Analysis

Bear Case

$29.32

146.2%

Low target

Base Case

$45.40

+281.2%

Avg target

Bull Case

$54.46

+357.3%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$26.95

-55.8% from high

52-Week Low

$3.55

+235.5% from low

Target vs 52W High

$45.40

+68.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%